ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NLMs Grateful MED Aids Data Searches

March 21, 1986

NCI Presents More Evidence f Program Accomplishments; Candlelighters Call For New Pediatric Effort, Including Regional Centers

April 6, 1979

ASCO To Begin Large Study On Quality Of Cancer Care.

January 28, 2000

Mack, Specter Hit White House Budget Proposal For NIH.

February 18, 2000

ASCO Board Accepts Plan To Establish New Bethesda Headquarters, Hire Chief Officer

April 23, 1993

Surgical Oncology Status A Disaster, DCT board Told; Kramer Describes Radiotherapy Needs

April 20, 1979